Inventor
NARENDRAN ARU
CA8 patents
Patents
8 patentsUS11058664B2Jul 13, 2021
In vitro and xenograft anti-tumor activity of a halogenated-xanthene against refractory pediatric solid tumors
PROVECTUS PHARMATECH INC1 citations69
US12377068B2Aug 5, 2025
In vitro and xenograft anti-tumor activity of a halogenated-xanthene against refractory pediatric solid tumors
PROVECTUS PHARMATECH INC0 citations59
US11974980B2May 7, 2024
In vitro and xenograft anti-tumor activity of a halogenated-xanthene against refractory pediatric solid tumors
PROVECTUS PHARMATECH INC0 citations59
US12133840B2Nov 5, 2024
Halogenated xanthene composition and method for treating hematologic cancers
PROVECTUS PHARMATECH INC0 citations58
US11419844B2Aug 23, 2022
Halogenated xanthene composition and method for treating hematologic cancers
PROVECTUS PHARMATECH INC0 citations58
US12064507B2Aug 20, 2024
Composition and method for oral treatment of leukemia
PROVECTUS PHARMATECH INC0 citations55
US11975106B2May 7, 2024
Uses of halogenated xanthenes in oncology and virology
PROVECTUS PHARMATECH INC0 citations55
US11938182B2Mar 26, 2024
Halogenated xanthenes as vaccine adjuvants
PROVECTUS PHARMATECH INC0 citations53